spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Sapphire 

 HSMN NewsFeed - 21 Aug 2025
FDA Clearance of Salix(R) Coronary Plaque Module
Devices Cardiology FDA
 HSMN NewsFeed - 27 Apr 2023
Eitan Medical launches connected Avoset(TM) Infusion Platform
Devices Product Launch
 HSMN NewsFeed - 6 Dec 2021
Biohaven Names CEO Vlad Coric, MD, Chairman Of The Board Of Directors And Matthew Buten, Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Sep 2021
Eitan Medical Announces Updated Distribution Arrangement
Devices Distribution
 HSMN NewsFeed - 12 Jul 2021
Cardiff Oncology Announces the Appointments of Katherine L. Ruffner, M.D., as Chief Medical Officer and James E. Levine as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 May 2021
TricValve(R) Transcatheter Bicaval Valves System Receives CE Mark
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 19 Jan 2021
Eitan Medical Receives FDA Clearance for Upgraded Sapphire(TM) Infusion Pump System
Devices FDA
 HSMN NewsFeed - 4 Jan 2021
Cognoptix Appoints New Chief Medical Officer, Dr. Carl Sadowsky, MD, And Chief Financial Officer, Mike Kaswan, MBA, To Management Team
Diagnostics Neurology Personnel
 HSMN NewsFeed - 9 Nov 2020
OrbusNeich(R) Medical and P+F Products & Features(R) announce new partnership
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 23 Sep 2020
OrbusNeich(R) Announces China Approval for COMBO(R) Coronary Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 25 Sep 2019
OrbusNeich(R) Announces Japan Approval for COMBO(R) Plus Coronary Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 11 Jun 2019
Eitan Group Adds Healthcare Veteran Chris Lowery to Board of Directors
Devices Drug Delivery Personnel
 HSMN NewsFeed - 27 Mar 2017
Bridge Medicines Appoints William J. Polvino, M.D., As Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Nov 2016
OrbusNeich Introduces a New Generation COMBO Plus Dual Therapy Stent for Active Healing
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 8 Jul 2016
NEPHROCHECK(R) Test Predicts Acute Kidney Injury Risk In Sepsis Patients Including Those With Other Organ Failures
Diagnostics
 HSMN NewsFeed - 27 Aug 2015
Hospira Announces First Installation of Plum 360(TM) Infusion System With Hospira MedNet
Devices Drug Delivery Product Launch
 HSMN NewsFeed - 19 May 2015
FDA Grants Premarket Approval for Silk Road Medical's ENROUTE(R) Transcarotid Stent System
Devices Interventional FDA
 HSMN NewsFeed - 18 Sep 2014
Latest Data Shows OrbusNeich's COMBO(TM) Dual Therapy Stent has Excellent Healing Benefits
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Jul 2014
First Patient Enrolment in MASCOT Registry Represents Major Milestone for COMBO(TM) Dual Therapy Stent and OrbusNeich's Clinical Programme
Devices Interventional Cardiology
 HSMN NewsFeed - 23 May 2014
OrbusNeich Releases Long-term Data for World's First and Only Dual Therapy Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Mar 2014
Cutera Introduces Two New Laser Systems
Devices Dermatology Product Launch
 HSMN NewsFeed - 15 Jan 2014
Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc.
Biopharmaceuticals Devices Mergers & Acquisitions
 HSMN NewsFeed - 16 Dec 2013
Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
Biopharmaceuticals Devices Mergers & Acquisitions
 HSMN NewsFeed - 17 Sep 2013
OrbusNeich, Boston Scientific Settle Patent Litigation
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 6 Aug 2013
First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich's COMBO Dual Therapy Stent(TM) in Routine Practice
Devices Interventional Cardiology
 HSMN NewsFeed - 27 May 2013
OrbusNeich Launches World's First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 22 May 2013
OrbusNeich's Genous(TM) Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 21 May 2013
OrbusNeich seizes Boston Scientific stents in Germany as part of patent infringement proceedings
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 20 May 2013
OrbusNeich's Genous(TM) Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 7 May 2013
OrbusNeich enforces injunction against Boston Scientific in Germany
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 30 Apr 2013
OrbusNeich obtains preliminary injunction in patent infringement proceedings in Germany against Boston Scientific
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 8 Mar 2013
OrbusNeich File Patent Infringement Lawsuit Against Boston Scientific in Ireland
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 20 Feb 2013
OrbusNeich Files Patent Infringement Actions Against Boston Scientific in Germany and the Netherlands
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 12 Feb 2013
OrbusNeich Announces Favorable Ruling From the European Patent Office
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Jan 2013
OrbusNeich's COMBO Dual Therapy Stent(TM) to Be Featured During AsiaPCR/SingLIVE 2013 Symposium
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Oct 2012
OrbusNeich's COMBO Dual Therapy Stent(TM) to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012
Devices Interventional Cardiology
 HSMN NewsFeed - 17 May 2012
Early Coronary Artery Healing Advantage of OrbusNeich's Combo Dual Therapy Stent(TM) Compared to the TAXUS(R) Stent Shown in Two Clinical Trial Subgroup Analyses
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Apr 2012
Spectrum Pharmaceuticals Commences Tender Offer for All Outstanding Shares of Allos Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Apr 2012
Spectrum Pharmaceuticals to Acquire Allos Therapeutics: Acquisition Expected to Be Accretive on a Cash Basis in Q4 of 2012
Biopharmaceuticals Mergers & Acquisiitons
 HSMN NewsFeed - 22 Mar 2012
OrbusNeich's Genous(TM) Technology Effectively Promotes Endothelialization and Reduces Thrombogenicity
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Jan 2012
OrbusNeich's Genous(TM) Stent Achieves Good, Comparable Clinical Outcomes in Patients Discontinuing Dual Antiplatelet Therapy at 30 Days and at Six Months
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Dec 2011
Data Published in EuroIntervention Indicate that OrbusNeich's Genous(TM) Stent Is Safe with Very Short-Term Dual Antiplatelet Therapy
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Jul 2011
OrbusNeich's Genous Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Mar 2011
Data Published in the Journal of Interventional Cardiology Demonstrate Effectiveness and Safety of OrbusNeich's Genous Stent in Diabetic Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Mar 2011
OrbusNeich Files Lawsuit Against Dr. Pavel Cervinka for Defamation
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 14 Mar 2011
OrbusNeich Announces Availability of Azule Cobalt Chromium Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Feb 2011
OrbusNeich Announces Availability of Next-Generation Sapphire II Coronary Dilatation Catheter
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Feb 2011
Published Data From e-HEALING Registry Demonstrate Good Clinical Outcomes With Low Incidence of Repeat Revascularization and Stent Thrombosis for OrbusNeich's Genous Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Jan 2011
Safety and Efficacy of OrbusNeich's Genous Stent Demonstrated in High-Risk Patients with Known Contraindications for Dual Antiplatelet Therapy
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Jan 2011
Neuroptix Closes C Round Financing
Devices Neurology Venture Capital
 HSMN NewsFeed - 2 Dec 2010
OrbusNeich's Genous Stent Shows Favorable Outcomes for Treatment of Coronary Artery Bifurcation Lesions Compared to Bare Metal Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Dec 2010
OrbusNeich Issues Statement on Boston Scientific's Unsuccessful Retaliatory Litigation Efforts in the Netherlands
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 27 Sep 2010
Acclarent, Inc. Introduces Two New Innovations for Minimally-Invasive Sinus Surgery during AAO - Head and Neck Surgery Conference
Devices Surgery
 HSMN NewsFeed - 24 Sep 2010
Patient Enrollment Completed in First Randomized Clinical Study of OrbusNeich's Combo Bio-engineered Sirolimus Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Jun 2010
Data Show OrbusNeich's Genous Bio-engineered R stent is Safe and Effective in Combination with Drug-Eluting Balloon
Devices Interventional Cardiology
 HSMN NewsFeed - 26 May 2010
Data Presented at EuroPCR 2010 Demonstrate Effectiveness of OrbusNeich's Genous Bio-engineered R stent in Diabetic Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Apr 2010
OrbusNeich Announces Full Availability of Genous(TM) Bio-engineered Cobalt Chromium Stent Following CE Mark Approval
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 14 Apr 2010
OrbusNeich Granted Patent for 'Stent with Helical Elements' - Patent Infringement Case Against Boston Scientific Expanded
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 11 Feb 2010
OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Feb 2010
OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Good Safety and Clinical Outcomes in Patients with Primary PCI for STEMI
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Dec 2009
Al Novak Elected Chairman of the Board of OrbusNeich Medical
Devices Interventional Personnel
 HSMN NewsFeed - 2 Dec 2009
LifeCycle Pharma Promotes Dr. William J. Polvino as New President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Dec 2009
OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2009
OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Safe in a Broad Population of Patients with Primary PCI for STEMI
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2009
Final 12 Month Clinical Data from 5,000 Patients in Worldwide e-HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM)
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2009
Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Compared to Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Apr 2009
OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Impressive Results in Higher Risk Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Mar 2009
OrbusNeich Files Patent Infringement Lawsuit Against Boston Scientific
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 11 Feb 2009
Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument
Diagnostics FDA
 HSMN NewsFeed - 28 Jan 2009
Helsinn Announces the Acquisition of Sapphire Therapeutics Inc., USA to Establish Helsinn Therapeutics (US) Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Oct 2008
Neuroptix Raises $18.5 Million in Successful B Round
Diagnostics Neurology Venture Capital
 HSMN NewsFeed - 28 Jul 2008
OrbusNeich Adds Sapphire(TM) NC Coronary Dilatation Catheter to Product Line-Up
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 7 Jul 2008
Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Jul 2008
Agios Pharmaceuticals Closes $33 Million Series A Funding
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 9 Jun 2008
OrbusNeich Receives CE Mark Approval for Scoreflex(TM) Coronary Dilatation Catheter
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 28 May 2008
OrbusNeich Receives Approval to Market Genous(TM) Bio-engineered R stent(TM) in Taiwan
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 15 May 2008
Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Apr 2008
OrbusNeich Receives CE Mark Approval for Sapphire(TM) 1.25MM PTCA Dilatation Catheter
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Feb 2008
OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Feasible in Acute Myocardial Infarction Patients, American Heart Journal Paper Reports
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Feb 2008
Tissue Extraction Devices Files a Patent Infringement Lawsuit Against Hologic, Inc. and Suros Surgical Systems, Inc.
Devices Litigation
 HSMN NewsFeed - 12 Feb 2008
Sapphire Therapeutics Promotes Suzan Allen to Vice President Clinical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Nov 2007
5,000 Patients Treated With OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Now Enrolled in Real-Life Use Global Registry
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2007
Next Generation Devices to Treat Clogged Neck Arteries Launched in U.S. and Europe
Devices Interventional
 HSMN NewsFeed - 17 Oct 2007
Cordis Corporation Announces Clinical Studies and Events at TCT 2007
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Sep 2007
Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Jul 2007
OrbusNeich Expands Global Sales and Marketing Team
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 23 May 2007
Efficacy of OrbusNeich's Genous(TM) Bio-Engineered R Stent Compares Favorably to Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 21 May 2007
OrbusNeich Receives CE Mark Approval for Blazer(TM) Cobalt Chromium Stent, Sapphire(TM) PTCA Dilatation Catheter, Lumina(TM) Guiding Catheter
Devices Regulatory Interventional Cardiology
 HSMN NewsFeed - 28 Mar 2007
AngioDynamics Names D. Joseph Gersuk Chief Financial Officer
Devices Interventional Personnel
 HSMN NewsFeed - 27 Mar 2007
Sapphire Therapeutics, Inc. Promotes William Polvino to CEO, Herb Conrad Elected Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Feb 2007
New Version of Devices to Treat Clogged Neck Arteries Approved by U.S. Food and Drug Administration
Devices Interventional FDA
 HSMN NewsFeed - 26 Oct 2006
Sapphire Therapeutics, Inc. Licenses Novel Drug to Ono Pharmaceuticals in Japan, Korea and Taiwan for the Treatment of Cancer Anorexia/Cachexia
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 16 Oct 2006
Enzo Biochem Appoints Gary C. Cupit, Former Novartis Pharmaceutical Executive, President of Enzo Therapeutics Unit
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Oct 2006
Hologic to Showcase the Latest in Women's Imaging & Skeletal Health Innovations at the Largest Medical Show in the World - RSNA'06
Devices Radiology
 HSMN NewsFeed - 26 Sep 2006
U.S. Food and Drug Administration Approves New Medical Devices to Treat Clogged Neck Arteries
Devices Interventional FDA
 HSMN NewsFeed - 19 Sep 2006
Sapphire Therapeutics, Inc. Licenses Ghrelin Mimetic From Novo Nordisk
Biopharmaceuticals Gastroenterology Surgery Licensing
 HSMN NewsFeed - 19 Jul 2006
Abbott Announces FDA Clearance of Cell-Dyn Ruby(TM) Hematology Instrument
Diagnostics FDA
Return to NewsFeed  

 Additional items found! 38

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 38 additional stories matching:
Sapphire
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!